PRe-treatment 68Ga-PSMA PET/CT parameters could predict response to 177Lu-PSMA tretament and overall survival in metastatic castration resistant prostate carcinoma patients treated with 177Lu-PSMA

---

ÖZKAN E., DEMİR B., ÖZTÜRK M., ARAZ M., SOYDAL Ç., DURSUN B., ...Daha Fazla

Annuals Congress of the European Association of Nuclear Medicine, 9 - 13 Eylül 2023, (Tam Metin Bildiri)

• Yayın Türü: Bildiri / Tam Metin Bildiri
• Ankara Üniversitesi Adresli: Evet